Regulatory Story Murray Income Trust PLC - MUT Released 16:20 17-Feb-2015 RNS Number : 1631F Murray Income Trust PLC 17 February 2015 Murray Income Trust PLC Half-yearly Report for the 6 months ended 31 December 2014 The Directors of Murray Income ... London Stock Exchange, 2 weeks ago
Murray Income Trust PLC Half Yearly Report - ADVFN UK, 2 weeks ago
1 images for "biotechnology regulatory authority of india b"
By Last year, 2014, marked the nineteenth year of the successful commercialisation of biotech crops. There has been a more than a hundred-fold increase in the area under these crops. Since 1996, this has expanded from 1.7 million hectares to 181.5 ...Uganda Daily Monitor, 3 weeks ago
Regulatory Story Polar Cap Gbl Healthcare Growth&IT - PCGH Released 07:00 16-Dec-2014 RNS Number : 8320Z Polar Cap Gbl Healthcare Growth&IT 16 December 2014 POLAR CAPITAL GLOBAL HEALTHCARE GROWTH AND INCOME TRUST PLC ANNUAL RESULTS ANNOUNCEMENT ...London Stock Exchange, 2 months ago
LEXINGTON, Mass., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. ( Nasdaq:CRIS ), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today reported its financial ...Franklin Credit Management Corporation, 1 week ago Curis, Inc. Reports Fourth Quarter And Year-End 2014 Financial Results BioSpace, 1 week ago
More from: Reuters, Town Hall...and 22 other sources
Preclinical Melioidosis Results Presented at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC
The Company's proprietary innate defense regulator (IDR) technology, including SGX943, have been specifically developed to target the host response to infection (not the bacteria) making them broadly applicable to many bacterial infections.Morningstar.com, 3 weeks ago 12635 E. Montview Blvd. Release: Preclinical Melioidosis Results Presented At The 2015 Biodefense And Emerging Diseases Research Meeting In Washington, DC BioSpace, 3 weeks ago SOLIGENIX : Preclinical Melioidosis Results Presented at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC 4 Traders, 3 weeks ago Soligenix Announces Presentation and Poster at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC Financial Content, 1 month ago
More from: Finwin, Minyanville...and 37 other sources
Posted 25/04/2014 Russian biotechnology company Biocad announced on 17 April 2014 that the Russian Ministry of Health has approved the company's rituximab non-originator biological, AcellBia (BCD-020). The drug is a non-originator biological of ...GaBi Online, 3 weeks ago
Vaccine Manufacturing and Production is an invaluable reference on how to produce a vaccine - from beginning to end - addressing all classes of vaccines from a processing,production, and regulatory viewpoint. It will provide comprehensive ...Research and Markets, 3 weeks ago
FEATURED COMPANIES A. R. Life Sciences Biocon Elder Pharmaceuticals Hikal Mangalam Drugs & Organics Shasun Pharmaceuticals MORE About Active Pharmaceutical Ingredients ...Research and Markets, 1 month ago
Predictions And Outlook For EPA's Office Of Chemical Safety And Pollution Prevention (OCSPP) 2015: 2015 will be a very interesting year. There are two overarching considerations that will make the year more difficult to predict than merely assuming ...JD Supra, 1 month ago
/PRNewswire/ -- Report Details Translational Regenerative Medicine - new study showing you trends, R&D progress, and predicted revenues Where is the market for regenerative medicine heading? What are the commercial prospects for this market ...ADVFN India, 5 days ago
on your WebpageAdd Widget >Get your members hooked!